Immune cell–specific SMN expression and sustained immune alterations in treated spinal muscular atrophy
Journal of Clinical Investigation · 02.11.2026 · 136 (21)
DOI: 10.1172/jci203540 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 25.08.2026. Verfasst von Ines Tapken und 17 weiteren Autor:innen. Beteiligte Einrichtung: TWINCORE-Centre for Experimental and Clinical Infection Research, a joint venture between the Hannover Medical School and the Helmholtz Centre for In…. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal, Survival of Motor Neuron 1 Protein, B-Lymphocytes, Dendritic Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hannover Medical School, SMA Europe, DFG.
Abstract (Originalsprache)
Mutations in the survival of motor neuron 1 ( SMN1 ) can reduce functional SMN protein levels, which causes spinal muscular atrophy (SMA), a disease affecting the nervous system and peripheral tissues, including the immune system. Yet, SMN expression across immune cell subsets and the effect of SMN-modulating therapies on the immune system remain underexplored. We found that in neonatal mouse spleens, SMN expression was highest in B cells, and was massively reduced in SMA mice. In human PBMCs from adults, DCs and monocytes expressed the highest SMN levels, whereas patients with SMA showed reduced DC frequencies and increased B cell frequencies. Patients receiving systemic versus CNS-restricted therapy showed similar differences in immune cell composition and SMN expression levels. Similarly, an exploratory cohort including untreated patients did not show a substantial treatment-specific effect relative to controls. To assess the effect of differentiation on SMN, we analyzed PMA-treated THP-1 cells and found enhanced aberrant SMN splicing and increased SMN + Cajal bodies. SMN levels varied across immune cell types, and reduced SMN levels were associated with altered immune cell composition. Immune alterations and decreased SMN levels were observed in both treated and untreated patients with SMA and may have contributed to dysfunctions of the immune system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- TWINCORE-Centre for Experimental and Clinical Infection Research, a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany.
- Centre for Individualised Infection Medicine (CiiM), a joint venture between the Helmholtz Centre for Infection Research and Hannover Medical School, Hannover, Germany.
- Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, and.
- Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.
- Hannover Biomedical Research School (HBRS) and Center for Infection Biology (ZIB), Hannover, Germany.
- Biomedical Research in End-Stage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.
Förderung
- Hannover Medical School
- SMA Europe
- DFG
Zitieren
APA
Tapken, I., Rahmel-Stein, K., Ehlers, C., Cieri, F., Detering, N. T., Schüning, T., Bjelica, B., Mindermann, C., Neuhoff, S., Schmitt, L. I., Leo, M., Hagenacker, T., Illsinger, S., Di Schiavi, E., Graalmann, T., Petri, S., Kalinke, U., & Claus, P. (2026). Immune cell–specific SMN expression and sustained immune alterations in treated spinal muscular atrophy. Journal of Clinical Investigation, 136(21). https://doi.org/10.1172/jci203540
Vancouver
Tapken I, Rahmel-Stein K, Ehlers C, Cieri F, Detering NT, Schüning T, et al. Immune cell–specific SMN expression and sustained immune alterations in treated spinal muscular atrophy. Journal of Clinical Investigation. 2026;136(21). doi:10.1172/jci203540
BibTeX
@article{Tapken2026,
author = {Tapken, Ines and Rahmel-Stein, Katharina and Ehlers, Christine and Cieri, Federica and Detering, Nora T and Schüning, Tobias and Bjelica, Bogdan and Mindermann, Charlotte and Neuhoff, Svenja and Schmitt, Linda-Isabell and Leo, Markus and Hagenacker, Tim and Illsinger, Sabine and Di Schiavi, Elia and Graalmann, Theresa and Petri, Susanne and Kalinke, Ulrich and Claus, Peter},
title = {Immune cell–specific SMN expression and sustained immune alterations in treated spinal muscular atrophy},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {21},
doi = {10.1172/jci203540}
}
EUVIMED